Helen M. Thackray Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Helen M. Thackray.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Helen M. Thackray. Helen M. Thackray is a Chief R&D Officer in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a SVP Clinical Development, CMO in GLYCOMIMETICS INC ($GLYC) and a VP Clinical Development, CMO in GLYCOMIMETICS INC ($GLYC).

Address: C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG 20879 MD

Companies in which Helen M. Thackray is an Insider

BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helen M. Thackray: Chief R&D Officer, Director
Holdings: 100,000 shares
Current Value: $567,000
Latest Transaction: Apr 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GLYCOMIMETICS INC

Trading Symbol: GLYC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Helen M. Thackray: SVP Clinical Development, CMO, VP Clinical Development, CMO
Holdings: 183,115 shares
Current Value: $1,146,300
Latest Transaction: Jan 22 2021
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Helen M. Thackray

Sentiment: All, BCRX, GLYC

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 02 2021BCRXBIOCRYST PHARMACEU ...Thackray Helen M.Chief R&D OfficerOption ExerciseA10.17400,0004,068,000400,000
Apr 02 2021BCRXBIOCRYST PHARMACEU ...Thackray Helen M.Chief R&D OfficerGrantA0.00100,0000100,0000 to 100 K
Jan 22 2021GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA3.8169,000262,89069,000
Jan 22 2021GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...GrantA0.0034,5000183,115148.6 K to 183.1 K (+23.21 %)
May 14 2020BCRXBIOCRYST PHARMACEU ...Thackray Helen M.DirectorOption ExerciseA5.4140,000216,40040,000
Jan 24 2020GLYCGLYCOMIMETICS INCThackray Helen M.SVP Clinical Develo ...Option ExerciseA4.72120,000566,400120,000
Sep 24 2019BCRXBIOCRYST PHARMACEU ...Thackray Helen M.DirectorOption ExerciseA2.8640,000114,40040,000

View all Helen M. Thackray insider transactions.